EGTX.ST STO
Egetis Therapeutics AB (publ)
1W: +16.5%
1M: +17.1%
3M: +55.6%
YTD: +77.6%
1Y: +74.5%
3Y: +121.7%
5Y: +70.6%
kr 9.18 ($0.91)
-0.26 (-2.75%)
Weekly Expected Move ±9.5%
kr 7
kr 8
kr 9
kr 10
kr 11
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
📊 Key Metrics
TTMkr 66M
Revenue
+39.5% YoY
kr -406M
Net Income
-20.3% YoY
kr -301M
Free Cash Flow
-24.1% YoY
20.7%
Gross Margin
-612.1%
Op. Margin
-625.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-97.0%
ROA-57.3%
ROIC-183.5%
Valuation
P/E-9.1
P/B8.6
EV/EBITDA-6.2
Leverage
Debt/Equity0.14
Current Ratio1.49
Interest Cov.-21.6x
Quality Scores
Piotroski F5/9
Altman Z0.29
Beneish M-4.08